Matches in Wikidata for { <http://www.wikidata.org/entity/Q73285983> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q73285983 description "articolo scientifico (pubblicato il 2000)" @default.
- Q73285983 description "artikull shkencor i botuar më 01 janar 2000" @default.
- Q73285983 description "artículu científicu espublizáu en xineru de 2000" @default.
- Q73285983 description "im Jahr 2000 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73285983 description "scientific article published on 01 January 2000" @default.
- Q73285983 description "wetenschappelijk artikel" @default.
- Q73285983 description "wüsseschaftlicher Artikel, wo im Johr 2000 veröffentlicht worden isch" @default.
- Q73285983 description "наукова стаття, опублікована в січні 2000" @default.
- Q73285983 name "Hyperimmunoglobulin prophylaxis, monitoring and preemptive ganciclovir treatment eliminate the risk of CMV infection to improve patient and renal allograft survival" @default.
- Q73285983 name "Hyperimmunoglobulin prophylaxis, monitoring and preemptive ganciclovir treatment eliminate the risk of CMV infection to improve patient and renal allograft survival" @default.
- Q73285983 name "Hyperimmunoglobulin prophylaxis, monitoring and preemptive ganciclovir treatment eliminate the risk of CMV infection to improve patient and renal allograft survival" @default.
- Q73285983 type Item @default.
- Q73285983 label "Hyperimmunoglobulin prophylaxis, monitoring and preemptive ganciclovir treatment eliminate the risk of CMV infection to improve patient and renal allograft survival" @default.
- Q73285983 label "Hyperimmunoglobulin prophylaxis, monitoring and preemptive ganciclovir treatment eliminate the risk of CMV infection to improve patient and renal allograft survival" @default.
- Q73285983 label "Hyperimmunoglobulin prophylaxis, monitoring and preemptive ganciclovir treatment eliminate the risk of CMV infection to improve patient and renal allograft survival" @default.
- Q73285983 prefLabel "Hyperimmunoglobulin prophylaxis, monitoring and preemptive ganciclovir treatment eliminate the risk of CMV infection to improve patient and renal allograft survival" @default.
- Q73285983 prefLabel "Hyperimmunoglobulin prophylaxis, monitoring and preemptive ganciclovir treatment eliminate the risk of CMV infection to improve patient and renal allograft survival" @default.
- Q73285983 prefLabel "Hyperimmunoglobulin prophylaxis, monitoring and preemptive ganciclovir treatment eliminate the risk of CMV infection to improve patient and renal allograft survival" @default.
- Q73285983 P1433 Q73285983-28640B7F-BE20-454C-97CC-C285D46709B0 @default.
- Q73285983 P1476 Q73285983-EE28FC0F-F490-4BCE-9CF3-EDFA70C16F4D @default.
- Q73285983 P2093 Q73285983-173CD7F0-18D3-4622-9023-E4C7B1BDC84A @default.
- Q73285983 P2093 Q73285983-89052250-211C-4E4A-B2FB-1DB27B5B62B2 @default.
- Q73285983 P2093 Q73285983-9AC91581-171A-44C7-AF99-80911F33EAAD @default.
- Q73285983 P2093 Q73285983-A5719B9F-2EA5-4C7F-A2AF-D920C0542190 @default.
- Q73285983 P2093 Q73285983-BA08F625-EC6B-47E2-9822-92773693771A @default.
- Q73285983 P2093 Q73285983-BF8AF17F-866F-46CD-B7F8-338952818AD7 @default.
- Q73285983 P2093 Q73285983-E88A9CA7-0403-4FC4-9E16-8204C8D333D6 @default.
- Q73285983 P2093 Q73285983-EB08B6CF-FD00-429E-B03C-2B7CB99FA631 @default.
- Q73285983 P2888 Q73285983-04257A1B-E573-4426-B86D-098E4F162F38 @default.
- Q73285983 P304 Q73285983-A59B6853-AB4B-49BD-8A32-638371162831 @default.
- Q73285983 P31 Q73285983-53978D52-2504-44CC-9C82-657A1F3BD2C0 @default.
- Q73285983 P356 Q73285983-B0064758-7E64-4910-BDB5-A1975CC2C105 @default.
- Q73285983 P478 Q73285983-4E8288F3-7712-4409-90F8-B4AE67919202 @default.
- Q73285983 P577 Q73285983-2D1BAF95-04C0-4109-B58E-66D0C15A4D2C @default.
- Q73285983 P6179 Q73285983-190B29C4-0BDA-4560-97D0-E58CC32FC4B2 @default.
- Q73285983 P698 Q73285983-89DB6608-B128-4460-8D1C-DF7DF0E76101 @default.
- Q73285983 P356 S001470050360 @default.
- Q73285983 P698 11112031 @default.
- Q73285983 P1433 Q15762140 @default.
- Q73285983 P1476 "Hyperimmunoglobulin prophylaxis, monitoring and preemptive ganciclovir treatment eliminate the risk of CMV infection to improve patient and renal allograft survival" @default.
- Q73285983 P2093 "B Zanker" @default.
- Q73285983 P2093 "H Schneeberger" @default.
- Q73285983 P2093 "J Theodorakis" @default.
- Q73285983 P2093 "M Pfeiffer" @default.
- Q73285983 P2093 "R Müller" @default.
- Q73285983 P2093 "S Aydemir" @default.
- Q73285983 P2093 "W D Illner" @default.
- Q73285983 P2093 "W Land" @default.
- Q73285983 P2888 s001470050360 @default.
- Q73285983 P304 "S354-8" @default.
- Q73285983 P31 Q13442814 @default.
- Q73285983 P356 "10.1007/S001470050360" @default.
- Q73285983 P478 "13 Suppl 1" @default.
- Q73285983 P577 "2000-01-01T00:00:00Z" @default.
- Q73285983 P6179 "1039595846" @default.
- Q73285983 P698 "11112031" @default.